Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-02-03

Clinical Trial Update: Comparative Effectiveness of Symbicort vs. Advair Among COPD Patients

View source ↗

Summary

A completed clinical trial comparing Symbicort (budesonide/formoterol) with Advair (salmeterol/fluticasone) in patients with chronic obstructive pulmonary disea…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Advair (fluticasone propionate/salmeterol)
  • Symbicort (budesonide/formoterol)

Snippet

Sponsor: AstraZeneca | Conditions: COPD | Status: COMPLETED